**Sunny Nephrology Clinic**

<!-- image -->

Anemia MANAGEMENT Protocol: ARANESP

| PURPOSE                                                                         | GOAL   |
|---------------------------------------------------------------------------------|--------|
| To achieve and maintain hemoglobin 10 or greater for ESRD patients with Anemia. | **INDICATOR	GOAL	FREQUENCY**  **Hemoglobin (HGB)**  9.0 g/dL-11.0 g/dL	Monthly, Bi-weekly, PRN  **Ferritin**  100-1000	Monthly, Bi-weekly, PRN  **T-Sat**  20-50	Monthly, Bi-weekly, PRN        |

**GENERAL GUIDELINES:**

- Target Range: Maintain hemoglobin between 10-11 g/dL
- Initiation Criteria: Do not initiate Aranesp unless HGB &lt; 10 g/dL
- Dose Adjustments:
    - Dose increases should be made monthly, unless otherwise directed by the physician
    - All dose changes require a new Aranep order to be written
- Maximum Dose Protocol: The maximum routine dose is 60 mcg weekly.  *Any dose above 60 mcg/week requires a physician’s verbal or written order.

**DOSING DISCRETION:**

- Initiation and titration may vary from protocol at physician’s discretion

**MONITORING:**

- **If Aranesp is held due to HGB &gt; 11 g/dL, monitor HGB bi-weekly**

**DOSE ROUNDING:**

- Round Aranesp doses to the nearest available prefilled syringe or single-dose vial. Available formulations include:
    - Pre-filled syringe: 10 mcg/0.4 ml, 25 mcg/0.42 ml, 40 mcg/0.4 ml, 60 mcg/0.3 ml, 100 mcg/0.5 ml, 150 mcg/0.3 ml, 200 mcg/0.4 ml, 300 mcg/0.6 ml, and 500 mcg/1 ml
    - Vial: 25 mcg/0.42 ml, 40 mcg/0.4 ml, 60 mcg/0.3 ml, 100 mcg/0.5 ml, 150 mcg/0.3 ml, 200 mcg/0.4 ml

**SPECIAL SITUATIONS:**

- New Patients Already on Aranesp:
    - If HGB is within target range, continue the current dose and monitor trends
    - If HGB is outside target, adjust dose using the protocol below
- Hospital Discharge (New or Existing ESRD Patients):
    - Obtain and review the patient’s most recent hospital HGB, if available
    - If HGB is not within goal, resume or adjust Aranesp per protocol

**Sunny Nephrology Clinic**

<!-- image -->

Anemia MANAGEMENT Protocol: ARANESP

**HOLDING ARANESP DOSING:**

| HEMOGLOBIN LEVELS            | ARANESP DOSING                                         |
|------------------------------|--------------------------------------------------------|
| HGB > 11.0 g/dL              | Continue to hold Aranesp                               |
| HGB > 10.5 g/dL              | Continue to hold Aranesp                               |
| HGB >10 g/dL and < 10.5 g/dL | Restart Aranesp with 50% reduction from previous dose  |
| HGB < 10 g/dL                | Restart Aranesp with 25 % reduction from previous dose |

**ARANESP DOSING ADJUSTMENT:**

| HEMOGLOBIN LEVELS   | HGB rises 1 g/dL per month   | HGB declines < 1 g/dL per month   | HGB declines > 1 g/dL per month   |
|---------------------|------------------------------|-----------------------------------|-----------------------------------|
| HGB > 11.0 g/dL     | Hold Aranesp                 | Hold Aranesp                      | Hold Aranesp                      |
| HGB 10.5-11.0 g/dL  | Decrease dose by 50%         | No Change                         | No change                         |
| HGB 10.0-10.5 g/dL  | Decrease dose by 25%         | No Change                         | Increase dose by 25%              |
| HGB < 10.0 g/dL     | No dose reduction            | Increase dose by 25%              | Increase dose by 50%              |

**EPOGEN/ARANESP CONVERSION TABLE:**

|                                   | Pt receiving Epogen 1x weekly       | Pt receiving Epogen 2-3x weekly   |
|-----------------------------------|-------------------------------------|-----------------------------------|
| PREVIOUS EPOGEN DOSE (Units/week) | **ARANESP DOSE**  **(MCG/2 weeks)** | **ARANESP DOSE**  **(MCG/week)**  |
| <2,499                            | 10                                  | ---------                         |
| 2,500-4,999                       | 10                                  | 10                                |
| 5,000-10,999                      | 25                                  | 25                                |
| 11,000-17,999                     | 40                                  | 40                                |
| 18,000-33,999                     | 60                                  | 60                                |
| 34,000-89,999                     | 100                                 | 100                               |
| >90,000                           | 200                                 | 200                               |